PFBT
IBB icon

Parkside Financial Bank & Trust’s iShares Biotechnology ETF IBB Stock Holding History

Parkside Financial Bank & Trust’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.1K Buy
267
+1
+0.4% +$171 ﹤0.01% 997
2025
Q4 		$44.9K Hold
266
– – ﹤0.01% 1003
2025
Q3 		$38.4K Buy
266
+87
+49% +$11.9K ﹤0.01% 1028
2025
Q2 		$22.7K Hold
179
– – ﹤0.01% 1188
2025
Q1 		$22.9K Buy
179
+25
+16% +$3.39K ﹤0.01% 1106
2024
Q4 		$20.4K Hold
154
– – ﹤0.01% 1089
2024
Q3 		$22.4K Hold
154
– – ﹤0.01% 1030
2024
Q2 		$21.1K Buy
154
+109
+242% +$14.6K ﹤0.01% 1014
2024
Q1 		$6.19K Buy
45
+25
+125% +$3.41K ﹤0.01% 1289
2023
Q4 		$2.73K Hold
20
– – ﹤0.01% 1442
2023
Q3 		$2.45K Hold
20
– – ﹤0.01% 1606
2023
Q2 		$2.55K Sell
20
-1,588
-99% -$206K ﹤0.01% 1611
2023
Q1 		$208K Sell
1,608
-263
-14% -$34.4K 0.06% 227
2022
Q4 		$246K Buy
1,871
+32
+2% +$4.14K 0.07% 201
2022
Q3 		$215K Sell
1,839
-53
-3% -$6.58K 0.07% 203
2022
Q2 		$223K Sell
1,892
-184
-9% -$21.8K 0.07% 201
2022
Q1 		$271K Hold
2,076
– – 0.07% 191
2021
Q4 		$317K Buy
2,076
+1,911
+1,158% +$296K 0.08% 177
2021
Q3 		$27K Hold
165
– – 0.01% 685
2021
Q2 		$27K Hold
165
– – 0.01% 682
2021
Q1 		$25K Buy
165
+14
+9% +$2.22K 0.01% 694
2020
Q4 		$23K Hold
151
– – 0.01% 678
2020
Q3 		$20K Hold
151
– – 0.01% 643
2020
Q2 		$21K Hold
151
– – 0.01% 627
2020
Q1 		$16K Hold
151
– – 0.01% 611
2019
Q4 		$18K Buy
151
+2
+1% +$223 0.01% 683
2019
Q3 		$15K Sell
149
-155
-51% -$16.2K ﹤0.01% 698
2019
Q2 		$33K Hold
304
– – 0.01% 493
2019
Q1 		$34K Hold
304
– – 0.01% 466
2018
Q4 		$29K Buy
+304
New +$32.3K 0.01% 478
2017
Q1 		– Sell
-360
Closed -$32K – 1424
2016
Q4 		$32K Hold
360
– – 0.01% 424
2016
Q3 		$35K Hold
360
– – 0.02% 446
2016
Q2 		$31K Buy
+360
New +$32.3K 0.02% 442

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Parkside Financial Bank & Trust's IBB Position: Q1 2026 in Review

Parkside Financial Bank & Trust increased its iShares Biotechnology ETF (IBB) stake by 0.38% in Q1 2026, buying an estimated $171 and bringing the position to 267 shares worth $45.1K. The position accounts for ﹤0.01% of the portfolio, ranked #997.

Parkside Financial Bank & Trust first reported a position in IBB in Q2 2016 and has held it in 33 quarters since. The position peaked at $317K in Q4 2021. 921 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Parkside Financial Bank & Trust held 267 shares of iShares Biotechnology ETF worth $45.1K as of Q1 2026.
  • Parkside Financial Bank & Trust bought 1 iShares Biotechnology ETF share in Q1 2026, an estimated $171.
  • iShares Biotechnology ETF made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #997 holding.
  • Parkside Financial Bank & Trust first reported a position in iShares Biotechnology ETF in Q2 2016 and has held it in 33 quarters since.
  • Parkside Financial Bank & Trust's iShares Biotechnology ETF position peaked at $317K in Q4 2021.
  • 921 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.